Inactive Instrument

Sector Chart RXi Pharmaceuticals Corp Nasdaq

Equities

US74979C5013

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
45.51B -
38.13B
38.52B
30.74B -
26.03B